- QMRO Home
- Barts Cancer Institute
- Centre for Experimental Cancer Medicine
- Patterns and potential benefit of adjuvant chemotherapy for residual muscle invasive disease after neoadjuvant chemotherapy for muscle invasive urothelial cancer (MIUC)
Browse
Administrators only